Earnouts in M&A: Risk allocation, incentives, and post-closing disputes
He examines a recent Delaware Supreme Court case between Johnson & Johnson and Auris Health, Inc., illustrating how courts would uphold the negotiated terms of...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA excel in all types of merger-related litigations. In contested mergers, we provide consulting and expert testimony on antitrust issues, merger efficiencies, merger synergies, analysis of weak and failing firms, and analysis of material adverse effects. In unsuccessful mergers, we analyze antitrust, causation, and damages issues. For completed mergers, we provide consulting and expert testimony in appraisal and breach of fiduciary duty actions on valuation, deal process and other corporate governance issues, and industry economics. In post-acquisition disputes, we address accounting, causation, and damages issues. In all matters, CRA experts apply cutting-edge research and state-of-the-art methods to our clients’ most complex challenges.
Vice President, Co-Practice Leader of Finance
Oakland
+1-510-595-2711 mattari@crai.comHe examines a recent Delaware Supreme Court case between Johnson & Johnson and Auris Health, Inc., illustrating how courts would uphold the negotiated terms of...
In this seventh edition of The Comprehensive Guide to Economic Damages, Vice President Renee McMahon contributed a chapter on representations and warranties...






